Advertisement

Topics

Latest "Amura Holdings Ltd" News Stories

17:01 EDT 22nd October 2018 | BioPortfolio

Here are the most relevant search results for "Amura Holdings Ltd" found in our extensive news archives from over 250 global news sources.

More Information about Amura Holdings Ltd on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Amura Holdings Ltd for you to read. Along with our medical data and news we also list Amura Holdings Ltd Clinical Trials, which are updated daily. BioPortfolio also has a large database of Amura Holdings Ltd Companies for you to search.

Showing "Amura Holdings" News Articles 1–25 of 1,600+

Monday 22nd October 2018

Senseonics Announces Aetna’s Positive Coverage Decision for Eversense

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that Aetna, the third largest commercial health plan provider in the United States, is providing coverage for Eversens...


Laboratory Corp of America Holdings LH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryLaboratory Corp of America Holdings LabCorp is a provider of clinical laboratory services and endtoend drug development support. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics laboratory services such as core testing, genomic and esoteric testing. Its services include general and sp...

Memphasys Ltd MEM Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryMemphasys Ltd Memphasys, formerly Nusep Holdings Ltd is a bioseparations company that develops and commercializes separation techniques based on its membrane technology. The company develops felix, a nonDNA damaging lab instrument for sperm separation that separates sperm from semen sample using electrophoresis and specialist membranes for the use in fertility treatments, including IVF for ...


Dance Biopharm Inc Medical Equipment Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryDance Biopharm Inc Dance Biopharm, a subsidiary of Dance Biopharm Holdings Inc, formerly Dance Pharmaceuticals Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients. The company's product pipeline includes Dance501, a pocketsized inhaler device and insulin container, among others. It has completed Phase II clinical trials and is in preparation for...

Global Orthopedic Trauma Fixation Devices Market Status and Outlook 20182025 [Report Updated: 13082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

IQVIA Holdings Inc. (IQV) CEO Ari Bousbib on Q3 2018 Results - Earnings Call Transcript

IQVIA Holdings, Inc. 2018 Q3 - Results - Earnings Call Slides

BioTime to Present New OpRegen® Data at American Academy of Ophthalmology Annual Meeting on October 28th

Abstract Selected to be Highlighted by the American Academy of Ophthalmology Organization Committee BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, announced today that updated results from a Phase I/IIa study of its lead product candidate, OpRegen®, a retinal pigment epithelium

IQVIA Reports Third-Quarter 2018 Results and Updates Full-Year 2018 Guidance

Revenue $2,594 million, up 6.3 percent at constant currency and 5.2 percent reported Adjusted EBITDA $561 million, up 8.4 percent at constant currency and 9.4 percent reported GAAP Diluted Earnings per Share $0.29 Adjusted Diluted Earnings per Share $1.42, up 19.3 percent $792 ...

United Therapeutics to Develop CollPlant Technologies for 3D Bioprinted Lung Transplants

United Therapeutics will license, develop, and commercialize CollPlant Holdings’ recombinant human collagen (rhCollagen) and BioInk technology for 3D bioprinting of solid-organ scaffolds for human transplants, the companies said today, through a collaboration that could generate more than $44 million. Through its wholly-owned organ manufacturing and transplantation-focused subsidiary Lung Bi...

PotNetwork Holding's Diamond CBD Brings Growing CBD Product Line to Denver, Colorado, for the Fall 2018 CHAMP Show

PotNetwork Holdings, Inc. (OTC Pink:POTN) is pleased to announce that its wholly owned subsidiary, Diamond CBD, Inc., hosted a booth at the latest Champs show, gea

Sunday 21st October 2018

North America Orthopedic Bone Cement and Casting Materials Market Outlook to 2025 [Report Updated: 01082018] Prices from USD $5995

North America Orthopedic Bone Cement and Casting Materials Market Outlook to 2025SummaryGlobalData's new report, North America Orthopedic Bone Cement and Casting Materials Market Outlook to 2025, provides key market data on the North America Orthopedic Bone Cement and Casting Materials market. The report provides value, in millions of US dollars, volume in units and average prices USD within marke...

Global Optical Patterned Wafer Inspection Equipment Market Status and Outlook 20182025 [Report Updated: 01082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Global Automated Test Equipment Market Status and Outlook 20182025 [Report Updated: 16082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Saturday 20th October 2018

Amarantus Bioscience Holdings Inc Medical Equipment Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryAmarantus Bioscience Holdings Inc Amarantus, formerly Amarantus BioSciences Inc is a biotechnology company that discovers and develops treatments for various therapeutic diseases. The company's therapeutics pipeline products include eltoprazine and mesencephalicastrocytederived neurotrophic factor. Its diagnostics include lymphocyte proliferation test, nuropro blood test and DNA sequencing ...

Takara Holdings Inc 2531 Financial and Strategic SWOT Analysis Review [Report Updated: 06092018] Prices from USD $125

Takara Holdings Inc 2531 Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment y...

Global and Asia Bone Casting Materials Market Status and Future Forecast 20132023 [Report Updated: 20082018] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...

Global OxygenFree Copper Market Status and Outlook 20182025 [Report Updated: 01082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Global RFID and Barcode Printer Market Status and Outlook 20182025 [Report Updated: 15082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

XuanZhu Pharma Co Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27082018] Prices from USD $250

SummaryXuanZhu Pharma Co Ltd XuanZhu, a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd, is a developer and manufacturer of medicinal products. The company's products comprise antiinfective drugs apapenem and benapenem; antiacid drug anaprazole sodium, antidiabetic drug imigliptin hydrochloride and antihypertensive drug tylerdipine hydrochloride. Its technology platforms include drug analys...

Genecast Acquires China Rights to Tumor Test from Cancer Genetics

Genecast Biotechnology of Beijing acquired exclusive China rights to the Tissue of Origin (TOO) test for difficult-to-identify tumors developed by Cancer Genetics of New Jersey. TOO, a microarray-based gene expression test, analyzes a tumor's genomic information to identify its origin, which helps to classify metastatic, poorly differentiated, or undifferentiated cancers. Founded in 2014, Genecast...

Friday 19th October 2018

Change Healthcare Holdings Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryChange Healthcare Holdings, Inc. Change Healthcare formerly Emdeon Inc. is a healthcare information technology company that provides software and analytics, network solutions and technologyenabled services. Some of its major solutions for payers, providers and pharmacies include revenue performance, network solutions, coverage discovery, consulting solutions, quality solutions, payment inte...

MeiraGTx acquires AAV gene therapy company Vector Neurosciences for up to $24mm

MeiraGTx Holdings PLC acquired privately held fellow gene therapy biotech Vector Neurosciences Inc. in an all-stock transacti...

Morphic closes $80mm Series B

Morphic Therapeutic Inc. (working on oral integrin therapies for autoimmune diseases, fibrotic diseases, and cancer) raised $...

Parkit announces completion of 15% IRR hurdle within the OP Holdings JV LLC

VANCOUVER, Oct. 19, 2018 /PRNewswire/ - Parkit Enterprise Inc. ("Parkit" or the "Company") (TSXV: PKT; OTCQX: PKTEF) is extremely pleased to announce it has reached Read more...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks